查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1861481

人工淚液市場按產品類型、活性成分、分銷管道、應用和容量類型分類－2025-2032年全球預測

Artificial Tears Market by Product Type, Active Ingredient, Distribution Channel, Application Type, Volume Type - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，人工淚液市場規模將達到 42.9 億美元，複合年成長率為 8.52%。

主要市場統計數據
基準年 2024 22.3億美元
預計年份：2025年 24.2億美元
預測年份：2032年 42.9億美元
複合年成長率 (%) 8.52%

人工淚液市場策略概覽：清楚剖析臨床需求促進因素、配方多樣性、成分選擇以及不斷發展的分銷管道

本報告清楚闡述了人工淚液市場格局轉變的背景，以及這些轉變對生產商、臨床醫生、付款者和經銷商的重要性。人口結構變化、電子設備使用量的增加、隱形眼鏡的普及以及前節手術數量的上升，都在推動對緩解症狀的眼部潤滑劑和治療製劑的需求。這些臨床和行為因素，以及患者對耐受性、療效和便利性的日益成長的期望，正推動產品從傳統的眼藥水和眼膏轉變為凝膠和噴霧劑的轉變。

識別正在重新定義人工淚液的變革性變化，包括成分創新、包裝演變、數位管道拓展和監管壓力。

技術、法規和消費者趨勢的融合正在推動行業變革。成分創新正在加速，製造商優先考慮透明質酸的各種變體和分子量工程，以最佳化產品保留率和緩解症狀。同時，向無防腐劑產品的轉變正在重塑配方策略和生產要求，而無菌填充和無防腐劑多劑量技術的進步則開闢了新的商業性機會。

深入評估供應鏈、籌資策略、價格壓力以及製造商對2025年實施的關稅累積影響的因應措施。

這些於2025年實施的關稅產生了累積效應，波及採購、製造和分銷管道的經濟層面。對某些進口活性物質、用於多劑量系統的特殊聚合物以及包裝組件徵收更高的關稅，加劇了依賴全球供應鏈的製造商的成本壓力。因此，採購部門加快了雙重採購策略，並尋求與區域供應商建立更緊密的合作關係，以降低貿易波動帶來的風險。對於高分子量透明質酸和用於無防腐劑給藥系統的特殊塑膠等原料，關稅反而促使企業加強上游整合獎勵，並簽訂長期供應協議。

詳細的細分分析，揭示影響策略的產品類型、活性成分偏好、分銷管道、應用場景和容量規格。

這種細分方法為將臨床需求和商業性機會轉化為具體的產品通路策略提供了切實可行的觀點。產品類型細分為眼藥水、凝膠、軟膏和噴霧劑。眼藥水進一步細分為乳劑、溶液和混懸劑；凝膠細分為低滲透壓和等滲透壓；軟膏細分為羊毛脂基、聚對苯二甲酸乙二醇酯（PET）基和其他拉丁美洲產軟膏；噴霧劑細分為噴霧和溶液。這種細分至關重要，因為每種亞型在配方、儲存要求、患者偏好以及生產和監管方面都存在不同的挑戰。

區域情報：整合美洲、歐洲、中東、非洲和亞太地區的需求促進因素、監管環境、製造地和分銷管道採用趨勢。

區域趨勢帶來了截然不同的商業和營運需求。在美洲，患者可近性、直接面對消費者的行銷以及強大的線上管道應用，與強調產品安全和標籤清晰度的法規環境並存。美洲製造商傾向於優先考慮快速供貨和全通路庫存策略，該地區仍然是無防腐劑產品差異化和支持長期用藥的訂閱模式的主要目標市場。

公司洞察分析了成熟製造商、靈活專業的公司、契約製造製造商和新參與企業如何重塑其產品組合、夥伴關係和商業化策略。

人工淚液市場的企業行為反映了策略多樣性。大型現有企業注重規模、監管應對力和廣泛的分銷網路，而專業企業和新參與企業則專注於細分市場差異化，例如無防腐劑技術和分子量最佳化的透明質酸。契約製造和合約研發組織正日益成為重要的合作夥伴，它們能夠快速大規模生產新配方，並能靈活應對關稅波動而調整採購管道。

為協助產業領導者加速成長、降低關稅風險、最佳化分銷並加強創新差異化，提供實際的優先建議。

產業領導者應優先考慮兼顧短期韌性和長期差異化的實際行動。首先，為降低關稅風險和供應中斷的影響，應實現關鍵原料和包裝籌資策略的多元化，並考慮建立區域製造夥伴關係或採用近岸外包模式，以獲得有利的監管和成本權衡。其次，隨著臨床差異化在專業人士和消費者的選擇中變得日益重要，應加快對無防腐劑遞送系統和深入臨床項目的投資，檢驗高分子量透明質酸與低分子量透明質酸的優勢。

我們採用透明的調查方法，詳細說明資料來源、專家諮詢、產品映射、供應鏈分析和檢驗方法，這些都構成了我們結論的基礎。

我們的研究途徑結合了系統性的二手資料分析、有針對性的原始研究以及嚴格的檢驗。二手資料包括同行評審的臨床文獻、監管指南和公開文件、專利狀態、供應商能力報告以及匿名化的管道績效指標。我們利用這些資訊來源建構了產品子類型、原料採購管道、容量規格和分銷機制的全面圖譜。原始研究包括對眼科醫生、醫院藥劑師、製劑工程師、包裝工程師以及來自製造商和經銷商的商業負責人進行結構化訪談，以了解營運限制和新興策略。

簡潔扼要的結論，對相關人員具有策略意義，重點在於韌性、以病人為中心的產品設計和工作優先順序。

人工淚液市場正處於變革的關鍵時期，臨床需求、包裝創新、數位化管道和貿易政策相互作用，共同重塑競爭格局。將配方科學（尤其是透明質酸分子變體和無防腐劑技術）與切實可行的供應鏈策略相結合的相關人員，將更有能力滿足臨床醫生的偏好和患者的便利需求。同時，深入了解從醫院藥房到品牌電商等各個分銷管道的獨特特性，對於將產品差異化轉化為永續的市場滲透至關重要。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 敏感眼部患者對不含防腐劑的人工淚液的需求日益成長
  • 整合奈米技術以改善淚液的滯留性和與眼表的黏附性
  • 消費者越來越偏好兼具潤滑和消炎功效的多功能眼藥水。
  • 在快速成長的新興市場中，市售乾眼症治療藥物的供應量正在擴大。
  • 在遠端醫療處方箋，處方箋級潤滑眼藥水的處方量激增
  • 開發緩釋水凝膠眼藥水以緩解緩釋性乾眼症狀
  • 在人工淚液配方中使用植物來源和天然成分
  • 創新的單劑量和多劑量包裝設計，實現精準給藥和便攜性

第6章美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 人工淚液市場（依產品類型分類）

  • 眼藥水
    • 乳液
    • 解決方案
    • 暫停
  • 凝膠
    • 低滲透壓
    • 等滲
  • 軟膏
    • 基於羊毛脂
    • 凡士林基
  • 噴
    • 薄霧
    • 溶液噴霧

第9章 人工淚液市場（依活性成分分類）

  • 羧甲基纖維素
  • 玻尿酸
    • 高分子量
    • 低分子量
  • 未添加防腐劑
  • 含防腐劑
    • 苯扎氯銨
    • 聚季銨鹽 1
    • 亞氯酸鈉

第10章 人工淚液市場（依通路分類）

  • 醫院藥房
  • 網路藥房
    • 品牌官方網站
    • 電子商務營運商
  • 零售藥房
    • 連鎖藥局
    • 獨立藥房
  • 超級市場大賣場超市

第11章 人工淚液市場依應用領域分類

  • 過敏性結膜炎
  • 乾眼症
    • 基本的
    • 次要
  • 緩解刺激
    • 溫和的
    • 緩和
    • 嚴重
  • 術後

第12章 人工淚液市場（依銷售量及種類分類）

  • 多劑量
    • 5-10毫升
    • 超過10毫升
    • 5毫升或更少
  • 單一劑量
    • 0.5毫升
    • 1毫升

第13章 人工淚液市場（依地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 人工淚液市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國人工淚液市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Alcon Inc.
    • Bausch+Lomb Corporation
    • Johnson & Johnson Consumer Inc.
    • Allergan plc
    • Santen Pharmaceutical Co., Ltd.
    • Rohto Pharmaceutical Co., Ltd.
    • Laboratoires Thea
    • Croma-Pharma GmbH
    • Similasan AG
    • Menicon Co., Ltd.
Product Code: MRR-69324464D1AA

The Artificial Tears Market is projected to grow by USD 4.29 billion at a CAGR of 8.52% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 2.23 billion
Estimated Year [2025] USD 2.42 billion
Forecast Year [2032] USD 4.29 billion
CAGR (%) 8.52%

A strategic introduction to the artificial tears landscape framing clinical demand drivers, formulation diversity, ingredient choices, and evolving distribution pathways

This report opens with a clear framing of what is changing in the artificial tears landscape and why those changes matter to manufacturers, clinicians, payers, and distributors. Demographic shifts, increased digital device exposure, expanded contact lens wear, and higher volumes of anterior segment procedures have all elevated demand for symptomatic ocular lubricants and therapeutic formulations. These clinical and behavioral drivers intersect with heightened patient expectations for tolerability, efficacy, and convenience, prompting product development that spans traditional drops and ointments through to gels and sprays.

Product diversity is more complex than it once was. Market offerings now include drops manufactured as emulsions, solutions, or suspensions; gels differentiated as hypotonic or isotonic; ointments formulated as lanolin-based or petrolatum-based; and sprays delivered as mists or solution sprays. Ingredient strategies layer onto that complexity, with choices between carboxymethylcellulose, hyaluronic acid in high or low molecular weight forms, and preservative-free versus preserved formats that use agents such as benzalkonium chloride, polyquaternium 1, or sodium chlorite. Distribution and dispensing pathways vary from hospital pharmacy to online storefronts and traditional retail, and volume formats span multi-dose containers across several milliliter bands and unit-dose offerings in 0.5 and 1 ml sizes. Together, these dynamics set the stage for an industry that must balance clinical performance, patient convenience, regulatory compliance, and commercial agility.

Identification of transformative shifts redefining artificial tears including ingredient innovation, packaging evolution, digital channel expansion, and regulatory pressures

The industry is undergoing transformative shifts driven by converging technological, regulatory, and consumer trends. Ingredient innovation has accelerated, with manufacturers prioritizing hyaluronic acid variants and molecular-weight engineering to optimize retention and symptom relief. At the same time, the shift toward preservative-free formats is reshaping formulation strategy and manufacturing requirements, while advances in aseptic filling and multi-dose preservative-free technologies are unlocking new commercial options.

Packaging and delivery innovation are equally consequential. Unit-dose formats are gaining traction where sterility and travel convenience are prioritized, while multi-dose containers continue to evolve across size bands to satisfy chronic use and cost sensitivity. The rise of online pharmacies, which includes brand-direct webstores and third-party e-retailers, is changing purchase behaviors and accelerating direct-to-consumer engagement. Retail pharmacy dynamics-where chain and independent outlets follow different stocking and promotional logics-are forcing manufacturers to introduce differentiated go-to-market tactics. Across applications, acoustics of demand have shifted; allergic conjunctivitis and post-surgical care require distinct clinical narratives compared with primary or secondary dry eye management. These structural shifts collectively demand that stakeholders reevaluate product roadmaps, channel investments, and evidence-generation plans to remain competitive.

Rigorous assessment of the cumulative impact of United States tariffs in 2025 on supply chains, sourcing strategies, pricing pressure, and manufacturer responses

The introduction of tariffs in the United States in 2025 has had a cumulative effect that ripples through procurement, manufacturing, and channel economics. Increased duties on certain imported active materials, specialty polymers used in multi-dose systems, and packaging components intensified cost pressures for manufacturers who rely on global supply chains. As a result, procurement teams accelerated dual-sourcing strategies and sought closer partnerships with regional suppliers to reduce exposure to further trade volatility. For inputs such as high molecular weight hyaluronic acid and specialized plastics for preservative-free delivery systems, the tariffs amplified incentives for upstream integration and long-term supply agreements.

These policy-induced cost dynamics also influenced product mix and channel tactics. Manufacturers with narrow margins reassessed the viability of certain lower-priced multi-dose SKUs and explored value engineering to maintain accessibility without degrading product performance. Distributors and retail partners recalibrated assortment strategies, with hospital pharmacies and chain retail outlets negotiating longer-term purchasing terms to stabilize supply. Online channels showed greater flexibility in absorbing incremental costs through tiered pricing or subscription models that smooth consumer spend. In parallel, some companies accelerated investments in domestic manufacturing and contract-filling capacity to sidestep duties, while regulatory teams intensified dialogue with authorities to ensure compliance and expedite approvals for relocated production. The net effect is a more complex commercial environment where supply chain resilience and sourcing strategy are as critical as formulation differentiation.

In-depth segmentation insights decoding product types, active ingredient preferences, distribution channels, application use cases, and volume formats influencing strategy

Segmentation offers a practical lens to translate clinical needs and commercial opportunity into concrete product and channel strategies. Product type segmentation spans drops, gels, ointments, and sprays, with further granularity for drops into emulsion, solution, and suspension formats; gels into hypotonic and isotonic versions; ointments as lanolin-based or petrolatum-based preparations; and sprays delivered as mist or solution spray. This granularity matters because each sub-type has distinct formulation challenges, preservation requirements, and patient preferences, and therefore different manufacturing and regulatory implications.

Active ingredient segmentation is equally influential. Options include carboxymethylcellulose, hyaluronic acid in high and low molecular weight configurations, preservative-free formulations, and preserved variants that deploy benzalkonium chloride, polyquaternium 1, or sodium chlorite. These ingredient decisions drive clinical positioning and influence shelf life, compatibility with packaging, and marketing claims. Distribution channel segmentation encompasses hospital pharmacy, online pharmacy-split between brand websites and e-retailers-retail pharmacy with chain and independent formats, and supermarkets or hypermarkets. Channel choice shapes promotional priorities, reimbursement pathways, and inventory management. Application type segmentation covers allergic conjunctivitis, dry eye syndrome including primary and secondary classifications, irritation relief across mild to severe gradations, and post-surgery care; each application implies different labeling, evidence needs, and clinician engagement strategies. Volume type segmentation differentiates multi-dose and unit-dose formats, with multi-dose broken into under 5 ml, 5 to 10 ml, and over 10 ml sizes, and unit-dose typically at 0.5 ml and 1 ml. These volume distinctions affect user convenience, regulatory categorization for sterility, and cost-to-manufacture calculations. Synthesizing these segmentation dimensions enables more precise targeting of R&D, regulatory dossiers, and commercial rollout plans.

Regional intelligence synthesizing demand drivers, regulatory landscapes, manufacturing footprints, and channel adoption trends across Americas, EMEA, and Asia-Pacific

Regional dynamics produce materially different commercial and operational imperatives. In the Americas, patient access, direct-to-consumer marketing, and strong online channel adoption coexist with a regulatory environment that emphasizes product safety and labeling clarity. Manufacturers serving the Americas often prioritize rapid fulfillment and omnichannel inventory strategies, and the region remains a prime target for differentiated preservative-free offerings and subscription models that support chronic use.

In Europe, the Middle East, and Africa, regulatory complexity and heterogeneous reimbursement systems necessitate tailored market entry strategies and careful compliance planning. European markets tend to emphasize clinical evidence and product quality claims, while certain Middle Eastern and African jurisdictions present opportunities for cost-sensitive multi-dose formats and regionally adapted packaging. In contrast, Asia-Pacific combines a dense manufacturing base with rapidly evolving clinical adoption. The region is notable for production capacity in active ingredients and primary packaging, which supports both global sourcing and localized manufacturing for tariff mitigation. Consumer behaviors also vary widely across the region; online pharmacies and brand websites are expanding quickly in some markets, while traditional retail remains dominant in others. Understanding these regional nuances is essential for aligning manufacturing locations, regulatory timelines, and channel investments with commercial outcomes.

Corporate insights into how established manufacturers, agile specialists, contract manufacturers, and new entrants are reshaping portfolios, partnerships, and commercialization approaches

Company behavior in the artificial tears space reflects strategic diversity: large incumbent manufacturers focus on scale, regulatory depth, and broad distribution networks, while specialist firms and newer entrants concentrate on niche differentiation such as preservative-free technologies or molecular-weight optimized hyaluronic acid. Contract manufacturers and contract development organizations are increasingly important partners, enabling faster scale-up for novel formulations and providing flexibility to respond to tariff-driven sourcing shifts.

Commercial strategies show a mix of consolidation and targeted partnerships. Established players are strengthening direct-to-consumer and professional relationships through co-marketing agreements and clinical evidence generation, while agile specialists invest in digital-first channels and sampling programs to accelerate trial. Packaging and device specialists are partnering with formulators to deliver multi-dose preservative-free solutions and user-friendly unit-dose systems. Across the ecosystem, companies are prioritizing quality systems, supply chain transparency, and traceability to meet regulatory scrutiny and clinician expectations. Successful firms also deploy differentiated evidence programs to substantiate claims for specific indications such as post-surgery care or severe dry eye, recognizing that robust clinical narratives materially affect uptake among prescribers and institutional buyers.

Actionable, prioritized recommendations for industry leaders to accelerate growth, mitigate tariff risks, optimize distribution, and enhance differentiation through innovation

Industry leaders should prioritize a set of practical actions that balance short-term resilience with long-term differentiation. First, diversify sourcing strategies for critical inputs and packaging to mitigate tariff exposure and supply interruptions, and evaluate nearshoring or regional manufacturing partnerships where regulatory and cost trade-offs are favorable. Second, accelerate investment in preservative-free delivery systems and in-depth clinical programs that validate high versus low molecular weight hyaluronic acid benefits, because clinical differentiation is increasingly central to professional and consumer choice.

Third, align commercial models with evolving channel dynamics by strengthening brand-direct channels and forming strategic partnerships with e-retail platforms while preserving relationships with hospital, chain, and independent pharmacies. Fourth, optimize packaging portfolios by balancing unit-dose convenience with the cost efficiencies of multi-dose systems across appropriate size bands, and assess reusable multi-dose technologies that meet sterility expectations. Fifth, invest in sustainability across packaging and supply chain operations to meet both regulatory scrutiny and consumer expectations. Finally, embed tariff-scenario planning into commercial and R&D roadmaps so that product launches, pricing strategies, and contractual commitments remain resilient under shifting trade policies. Prioritizing these steps will support both competitive differentiation and operational stability.

Transparent research methodology detailing data sources, expert consultations, product mapping, supply chain analysis, and validation techniques underpinning conclusions

The research approach combined systematic secondary analysis with targeted primary engagement and rigorous validation. Secondary inputs included peer-reviewed clinical literature, regulatory guidance and public filings, patent landscapes, supplier capability reports, and anonymized channel performance indicators. These sources were used to build a comprehensive mapping of product subtypes, ingredient pathways, volume formats, and distribution mechanics. Primary research comprised structured interviews with ophthalmologists, hospital pharmacists, formulators, packaging engineers, and commercial leaders across manufacturers and distributors to capture practical constraints and emergent strategies.

Data synthesis proceeded through triangulation methods to reconcile varying inputs and to surface consistent patterns across geographies and channel types. Supply chain mapping was used to identify concentrations of risk, particularly for high molecular weight hyaluronic acid and specialized packaging components. Scenario analysis was applied to evaluate the operational implications of tariff-related disruptions and to test the sensitivity of go-to-market models under differing channel mixes. Quality assurance steps included cross-validation of key findings with independent clinical and regulatory experts to ensure accuracy and to sharpen the implications for R&D, operations, and commercial teams. Limitations included variability in proprietary pricing and contract terms that remain confidential to firms, and where applicable, qualitative judgment was applied to interpret those signals.

Concise conclusion synthesizing strategic implications for stakeholders with emphasis on resilience, patient-centric product design, and operational prioritization

The artificial tears sector is at an inflection point where clinical expectations, packaging innovation, digital channels, and trade policy interact to reshape competitive dynamics. Stakeholders who integrate formulation science-especially around hyaluronic acid molecular variants and preservative-free technologies-with pragmatic supply chain strategies will be better positioned to respond to clinician preferences and patient convenience demands. Simultaneously, familiarity with channel nuances from hospital pharmacies through brand e-commerce is essential to translate product differentiation into sustainable adoption.

Operational resilience, particularly in sourcing and manufacturing footprint decisions, will be a defining capability given recent tariff-driven shifts. Companies that proactively align R&D, regulatory evidence generation, and distribution investments will capture disproportionate value by offering clinically substantiated, convenient, and accessible products. Ultimately, the ability to convert segmentation insight into focused portfolios, supported by flexible supply chains and channel-specific commercialization, will determine which organizations lead and which follow as the market evolves.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Rising demand for preservative-free artificial tears among sensitive eye patients
  • 5.2. Integration of nanotechnology to improve tear retention and ocular surface adherence
  • 5.3. Growing consumer preference for multi-action eye drops addressing lubrication and inflammation
  • 5.4. Expansion of over-the-counter dry eye treatments in high-growth emerging markets
  • 5.5. Surge in telehealth-driven prescriptions for prescription-strength lubricant eye solutions
  • 5.6. Development of sustained-release hydrogel eye drops for extended dry eye symptom relief
  • 5.7. Adoption of plant-derived and natural ingredients in artificial tear formulations
  • 5.8. Innovative single-dose and multi-dose packaging designs for accurate dosing and portability

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Artificial Tears Market, by Product Type

  • 8.1. Drops
    • 8.1.1. Emulsion
    • 8.1.2. Solution
    • 8.1.3. Suspension
  • 8.2. Gels
    • 8.2.1. Hypotonic
    • 8.2.2. Isotonic
  • 8.3. Ointments
    • 8.3.1. Lanolin Based
    • 8.3.2. Petrolatum Based
  • 8.4. Sprays
    • 8.4.1. Mist
    • 8.4.2. Solution Spray

9. Artificial Tears Market, by Active Ingredient

  • 9.1. Carboxymethylcellulose
  • 9.2. Hyaluronic Acid
    • 9.2.1. High Molecular Weight
    • 9.2.2. Low Molecular Weight
  • 9.3. Preservative Free
  • 9.4. With Preservatives
    • 9.4.1. Benzalkonium Chloride
    • 9.4.2. Polyquaternium 1
    • 9.4.3. Sodium Chlorite

10. Artificial Tears Market, by Distribution Channel

  • 10.1. Hospital Pharmacy
  • 10.2. Online Pharmacy
    • 10.2.1. Brand Website
    • 10.2.2. E Retailers
  • 10.3. Retail Pharmacy
    • 10.3.1. Chain Pharmacy
    • 10.3.2. Independent Pharmacy
  • 10.4. Supermarket Hypermarket

11. Artificial Tears Market, by Application Type

  • 11.1. Allergic Conjunctivitis
  • 11.2. Dry Eye Syndrome
    • 11.2.1. Primary
    • 11.2.2. Secondary
  • 11.3. Irritation Relief
    • 11.3.1. Mild
    • 11.3.2. Moderate
    • 11.3.3. Severe
  • 11.4. Post Surgery

12. Artificial Tears Market, by Volume Type

  • 12.1. Multi Dose
    • 12.1.1. 5 To 10 Ml
    • 12.1.2. Over 10 Ml
    • 12.1.3. Under 5 Ml
  • 12.2. Unit Dose
    • 12.2.1. 0.5 Ml
    • 12.2.2. 1 Ml

13. Artificial Tears Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Artificial Tears Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Artificial Tears Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Alcon Inc.
    • 16.3.2. Bausch + Lomb Corporation
    • 16.3.3. Johnson & Johnson Consumer Inc.
    • 16.3.4. Allergan plc
    • 16.3.5. Santen Pharmaceutical Co., Ltd.
    • 16.3.6. Rohto Pharmaceutical Co., Ltd.
    • 16.3.7. Laboratoires Thea
    • 16.3.8. Croma-Pharma GmbH
    • 16.3.9. Similasan AG
    • 16.3.10. Menicon Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ARTIFICIAL TEARS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY ACTIVE INGREDIENT, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY ACTIVE INGREDIENT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION TYPE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY VOLUME TYPE, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY VOLUME TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS ARTIFICIAL TEARS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA ARTIFICIAL TEARS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA ARTIFICIAL TEARS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL TEARS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE ARTIFICIAL TEARS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST ARTIFICIAL TEARS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA ARTIFICIAL TEARS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC ARTIFICIAL TEARS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN ARTIFICIAL TEARS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC ARTIFICIAL TEARS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION ARTIFICIAL TEARS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS ARTIFICIAL TEARS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 ARTIFICIAL TEARS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO ARTIFICIAL TEARS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. ARTIFICIAL TEARS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. ARTIFICIAL TEARS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. ARTIFICIAL TEARS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL ARTIFICIAL TEARS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL ARTIFICIAL TEARS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY DROPS, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY DROPS, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY DROPS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY DROPS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY DROPS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY DROPS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY DROPS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY DROPS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY EMULSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY EMULSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY EMULSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY EMULSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY EMULSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY EMULSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY SOLUTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY SOLUTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY SOLUTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY SOLUTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY SOLUTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY SOLUTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY SUSPENSION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY SUSPENSION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY SUSPENSION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY SUSPENSION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY SUSPENSION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY SUSPENSION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY GELS, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY GELS, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY GELS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY GELS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY GELS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY GELS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY GELS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY GELS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY HYPOTONIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY HYPOTONIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY HYPOTONIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY HYPOTONIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY HYPOTONIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY HYPOTONIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY ISOTONIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY ISOTONIC, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY ISOTONIC, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY ISOTONIC, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY ISOTONIC, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY ISOTONIC, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY OINTMENTS, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY OINTMENTS, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY OINTMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY OINTMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY OINTMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY OINTMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY OINTMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY OINTMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY LANOLIN BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY LANOLIN BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY LANOLIN BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY LANOLIN BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY LANOLIN BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY LANOLIN BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY PETROLATUM BASED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY PETROLATUM BASED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY PETROLATUM BASED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY PETROLATUM BASED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY PETROLATUM BASED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY PETROLATUM BASED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY SPRAYS, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY SPRAYS, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY SPRAYS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY SPRAYS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY SPRAYS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY SPRAYS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY SPRAYS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY SPRAYS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY MIST, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY MIST, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY MIST, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY MIST, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY MIST, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY MIST, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY SOLUTION SPRAY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY SOLUTION SPRAY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY SOLUTION SPRAY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY SOLUTION SPRAY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY SOLUTION SPRAY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY SOLUTION SPRAY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY CARBOXYMETHYLCELLULOSE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY CARBOXYMETHYLCELLULOSE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY CARBOXYMETHYLCELLULOSE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY CARBOXYMETHYLCELLULOSE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY CARBOXYMETHYLCELLULOSE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY CARBOXYMETHYLCELLULOSE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY HYALURONIC ACID, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY HYALURONIC ACID, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY HYALURONIC ACID, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY HYALURONIC ACID, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY HYALURONIC ACID, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY HYALURONIC ACID, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY HYALURONIC ACID, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY HYALURONIC ACID, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY HIGH MOLECULAR WEIGHT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY HIGH MOLECULAR WEIGHT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY HIGH MOLECULAR WEIGHT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY HIGH MOLECULAR WEIGHT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY HIGH MOLECULAR WEIGHT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY HIGH MOLECULAR WEIGHT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY LOW MOLECULAR WEIGHT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY LOW MOLECULAR WEIGHT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY LOW MOLECULAR WEIGHT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY LOW MOLECULAR WEIGHT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY LOW MOLECULAR WEIGHT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY LOW MOLECULAR WEIGHT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY PRESERVATIVE FREE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY PRESERVATIVE FREE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY PRESERVATIVE FREE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY PRESERVATIVE FREE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY PRESERVATIVE FREE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY PRESERVATIVE FREE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY WITH PRESERVATIVES, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY WITH PRESERVATIVES, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY WITH PRESERVATIVES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY WITH PRESERVATIVES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY WITH PRESERVATIVES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY WITH PRESERVATIVES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY WITH PRESERVATIVES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY WITH PRESERVATIVES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY BENZALKONIUM CHLORIDE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY BENZALKONIUM CHLORIDE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY BENZALKONIUM CHLORIDE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY BENZALKONIUM CHLORIDE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY BENZALKONIUM CHLORIDE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY BENZALKONIUM CHLORIDE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY POLYQUATERNIUM 1, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY POLYQUATERNIUM 1, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY POLYQUATERNIUM 1, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY POLYQUATERNIUM 1, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY POLYQUATERNIUM 1, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY POLYQUATERNIUM 1, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY SODIUM CHLORITE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY SODIUM CHLORITE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY SODIUM CHLORITE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY SODIUM CHLORITE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY SODIUM CHLORITE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY SODIUM CHLORITE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY ONLINE PHARMACY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY ONLINE PHARMACY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY ONLINE PHARMACY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY BRAND WEBSITE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY BRAND WEBSITE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY BRAND WEBSITE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY BRAND WEBSITE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY BRAND WEBSITE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY BRAND WEBSITE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY E RETAILERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY E RETAILERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY E RETAILERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY E RETAILERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY E RETAILERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY E RETAILERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY RETAIL PHARMACY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY RETAIL PHARMACY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY CHAIN PHARMACY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY CHAIN PHARMACY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY CHAIN PHARMACY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY CHAIN PHARMACY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY CHAIN PHARMACY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY INDEPENDENT PHARMACY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY INDEPENDENT PHARMACY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY INDEPENDENT PHARMACY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY INDEPENDENT PHARMACY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY INDEPENDENT PHARMACY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY SUPERMARKET HYPERMARKET, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY SUPERMARKET HYPERMARKET, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY SUPERMARKET HYPERMARKET, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY SUPERMARKET HYPERMARKET, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY SUPERMARKET HYPERMARKET, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY SUPERMARKET HYPERMARKET, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION TYPE, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY APPLICATION TYPE, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY ALLERGIC CONJUNCTIVITIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY ALLERGIC CONJUNCTIVITIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY ALLERGIC CONJUNCTIVITIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY ALLERGIC CONJUNCTIVITIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY ALLERGIC CONJUNCTIVITIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY ALLERGIC CONJUNCTIVITIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY DRY EYE SYNDROME, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY DRY EYE SYNDROME, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY DRY EYE SYNDROME, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY DRY EYE SYNDROME, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY DRY EYE SYNDROME, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY DRY EYE SYNDROME, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY DRY EYE SYNDROME, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY DRY EYE SYNDROME, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY PRIMARY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY PRIMARY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY PRIMARY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY PRIMARY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY PRIMARY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY PRIMARY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY SECONDARY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY SECONDARY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY SECONDARY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY SECONDARY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY SECONDARY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY SECONDARY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY IRRITATION RELIEF, 2018-2024 (USD MILLION)
  • TABLE 236. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY IRRITATION RELIEF, 2025-2032 (USD MILLION)
  • TABLE 237. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY IRRITATION RELIEF, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 238. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY IRRITATION RELIEF, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 239. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY IRRITATION RELIEF, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 240. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY IRRITATION RELIEF, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 241. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY IRRITATION RELIEF, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 242. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY IRRITATION RELIEF, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 243. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY MILD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 244. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY MILD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY MILD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY MILD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 247. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY MILD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 248. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY MILD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 249. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY MODERATE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 250. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY MODERATE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 251. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY MODERATE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 252. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY MODERATE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 253. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY MODERATE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 254. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY MODERATE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 255. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY SEVERE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 256. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY SEVERE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 257. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY SEVERE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 258. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY SEVERE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 259. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY SEVERE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 260. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY SEVERE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 261. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY POST SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 262. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY POST SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 263. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY POST SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 264. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY POST SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 265. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY POST SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 266. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY POST SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 267. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY VOLUME TYPE, 2018-2024 (USD MILLION)
  • TABLE 268. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY VOLUME TYPE, 2025-2032 (USD MILLION)
  • TABLE 269. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY MULTI DOSE, 2018-2024 (USD MILLION)
  • TABLE 270. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY MULTI DOSE, 2025-2032 (USD MILLION)
  • TABLE 271. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY MULTI DOSE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 272. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY MULTI DOSE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 273. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY MULTI DOSE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 274. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY MULTI DOSE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY MULTI DOSE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY MULTI DOSE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 277. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY 5 TO 10 ML, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 278. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY 5 TO 10 ML, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 279. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY 5 TO 10 ML, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 280. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY 5 TO 10 ML, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 281. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY 5 TO 10 ML, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 282. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY 5 TO 10 ML, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 283. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY OVER 10 ML, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 284. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY OVER 10 ML, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 285. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY OVER 10 ML, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 286. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY OVER 10 ML, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 287. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY OVER 10 ML, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 288. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY OVER 10 ML, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 289. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY UNDER 5 ML, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 290. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY UNDER 5 ML, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 291. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY UNDER 5 ML, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 292. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY UNDER 5 ML, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 293. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY UNDER 5 ML, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 294. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY UNDER 5 ML, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 295. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY UNIT DOSE, 2018-2024 (USD MILLION)
  • TABLE 296. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY UNIT DOSE, 2025-2032 (USD MILLION)
  • TABLE 297. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY UNIT DOSE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 298. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY UNIT DOSE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 299. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY UNIT DOSE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 300. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY UNIT DOSE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 301. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY UNIT DOSE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 302. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY UNIT DOSE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 303. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY 0.5 ML, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 304. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY 0.5 ML, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 305. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY 0.5 ML, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 306. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY 0.5 ML, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 307. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY 0.5 ML, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 308. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY 0.5 ML, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 309. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY 1 ML, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 310. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY 1 ML, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 311. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY 1 ML, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 312. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY 1 ML, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 313. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY 1 ML, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 314. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY 1 ML, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 315. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 316. GLOBAL ARTIFICIAL TEARS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 317. AMERICAS ARTIFICIAL TEARS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 318. AMERICAS ARTIFICIAL TEARS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 319. AMERICAS ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 320. AMERICAS ARTIFICIAL TEARS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 321. AMERICAS ARTIFICIAL TEARS MARKET SIZE, BY DROPS, 2018-2024 (USD MILLION)
  • TABLE 322. AMERICAS ARTIFICIAL TEARS MARKET SIZE, BY DROPS, 2025-2032 (USD MILLION)
  • TABLE 323. AMERICAS ARTIFICIAL TEARS MARKET SIZE, BY GELS, 2018-2024 (USD MILLION)
  • TABLE 324. AMERICAS ARTIFICIAL TEARS MARKET SIZE, BY GELS, 2025-2032 (USD MILLION)
  • TABLE 325. AMERICAS ARTIFICIAL TEARS MARKET SIZE, BY OINTMENTS, 2018-2024 (USD MILLION)
  • TABLE 326. AMERICAS ARTIFICIAL TEARS MARKET SIZE, BY OINTMENTS, 2025-2032 (USD MILLION)
  • TABLE 327. AMERICAS ARTIFICIAL TEARS MARKET SIZE, BY SPRAYS, 2018-2024 (USD MILLION)
  • TABLE 328. AMERICAS ARTIFICIAL TEARS MARKET SIZE, BY SPRAYS, 2025-2032 (USD MILLION)
  • TABLE 329. AMERICAS ARTIFICIAL TEARS MARKET SIZE, BY ACTIVE INGREDIENT, 2018-2024 (USD MILLION)
  • TABLE 330. AMERICAS ARTIFICIAL TEARS MARKET SIZE, BY ACTIVE INGREDIENT, 2025-2032 (USD MILLION)
  • TABLE 331. AMERICAS ARTIFICIAL TEARS MARKET SIZE, BY HYALURONIC ACID, 2018-2024 (USD MILLION)
  • TABLE 332. AMERICAS ARTIFICIAL TEARS MARKET SIZE, BY HYALURONIC ACID, 2025-2032 (USD MILLION)
  • TABLE 333. AMERICAS ARTIFICIAL TEARS MARKET SIZE, BY WITH PRESERVATIVES, 2018-2024 (USD MILLION)
  • TABLE 334. AMERICAS ARTIFICIAL TEARS MARKET SIZE, BY WITH PRESERVATIVES, 2025-2032 (USD MILLION)
  • TABLE 335. AMERICAS ARTIFICIAL TEARS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD M